B2DB — Who said what, where, and when

Peter Breunig

Dr., Abbvie Deutschland GmbH & Co.KG

Peter Breunig is listed as Dr., Abbvie Deutschland GmbH & Co.KG. Peter spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Bewegungsstörungen I”).

Compiled from published conference agendas; not yet confirmed by Peter. Is this you? Claim this profile.

Sessions at 1 conference

DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026